EX-16.1 8 f20f2022ex16-1_clearmind.htm LETTER FROM SATURNA GROUP CHARTERED PROFESSIONAL ACCOUNTANTS LLP, DATED FEBRUARY 2, 2023

Exhibit 16.1

 

A picture containing chart Description automatically generated

 

Re: Clearmind Medicine Inc. (the “Company”)

 

This letter will confirm that we reviewed Item 16F of the Company’s Form 20-F, which we understand will be filed with the United States Securities and Exchange Commission, on or about February 3, 2023, captioned “Change in the Registrant’s Certifying Accountant” and that we agree with the statements made therein as they relate to Saturna Group Chartered Professional Accountants LLP.

 

We hereby consent to the filing of this letter as an exhibit to the foregoing report on Form 20-F.

 

/s/ SATURNA GROUP CHARTERED PROFESSIONAL ACCOUNTANTS LLP

 

SATURNA GROUP CHARTERED PROFESSIONAL ACCOUNTANTS LLP

 

Vancouver, Canada

 

February 2, 2023